Great Lakes collaborates with Bangor University
Great Lakes Fine Chemicals (GLFC), based in Holywell in Wales, has entered into a collaborative research programme with the chemistry department at The University of Wales Bangor to investigate novel routes to the synthesis of amino acids.
Great Lakes Fine Chemicals (GLFC), based in Holywell in Wales, has entered into a collaborative research programme with the chemistry department at The University of Wales Bangor to investigate novel routes to the synthesis of amino acids.
The starting point for the collaboration is the proprietary asymmetric synthetic technologies acquired by GLFC when it purchased NSC Technologies in 1998. The initial task will be to identify key chemical and biochemical-based projects that have commercial applications or are of academic interest.
'The initial process of project identification will draw upon GLFC's extensive knowledge in asymmetric synthesis, including asymmetric hydrogenations and biotransformations,' said David Rowles, site general manager GLFC. 'These will be further developed in combination with Bangor's chemical and biochemical expertise. We will aim to establish new synthesis methodologies for amino acid derivatives, unnatural amino acids and chiral intermediates, based upon former MSC products and technologies.'
The initial phase of the study is being partly funded by a £10,000 (Euro 14,070) grant from the Welsh Development Agency.